REGENXBIO Inc. (RGNX) Insider Trading
Over the last 3 months, RGNX insiders made 0 open-market buys and 3 sales, a net sale of -$857K (SEC Form 4). Over the last 6 months, 130 institutions increased and 119 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
3
Net (3m)
-$857.5K
Insider trades by month Buys Sells
May
Sep
Oct
Mar
May
Jul
Context3-month price +53.5%Institutions mixed (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 1, 2026 | PAKOLA STEVEofficer: Chief Medical Officer | Option | 36,725 | $7.86 |
| Jul 1, 2026 | PAKOLA STEVEofficer: Chief Medical Officer | Sell | 19,608 | $11.04 |
| Jul 1, 2026 | PAKOLA STEVEofficer: Chief Medical Officer | Sell | 36,725 | $12.86 |
| Jun 2, 2026 | Bennett Jeandirector | Grant | 9,807 | — |
| Jun 2, 2026 | KARABELAS ARGERIS Ndirector | Grant | 9,807 | — |
| Jun 2, 2026 | Tasse Danieldirector | Grant | 46,600 | $7.01 |
| Jun 2, 2026 | STUMP DAVID Cdirector | Grant | 9,807 | — |
| Jun 2, 2026 | Bennett Jeandirector | Grant | 46,600 | $7.01 |
| Jun 2, 2026 | KARABELAS ARGERIS Ndirector | Grant | 46,600 | $7.01 |
| Jun 2, 2026 | MIGAUSKY GEORGE Vdirector | Grant | 46,600 | $7.01 |
| Jun 2, 2026 | Glucksmann Alexandradirector | Grant | 9,807 | — |
| Jun 2, 2026 | Fox Allan M.director | Grant | 46,600 | $7.01 |
| Jun 2, 2026 | Fox Allan M.director | Grant | 9,807 | — |
| Jun 2, 2026 | Glucksmann Alexandradirector | Grant | 46,600 | $7.01 |
| Jun 2, 2026 | Mills Kenneth T.director | Grant | 9,807 | — |
| Jun 2, 2026 | STUMP DAVID Cdirector | Grant | 46,600 | $7.01 |
| Jun 2, 2026 | Zachary Jenniferdirector | Grant | 9,807 | — |
| Jun 2, 2026 | Zachary Jenniferdirector | Grant | 46,600 | $7.01 |
| Jun 2, 2026 | Tasse Danieldirector | Grant | 9,807 | — |
| Jun 2, 2026 | Mills Kenneth T.director | Grant | 46,600 | $7.01 |
| Jun 2, 2026 | MIGAUSKY GEORGE Vdirector | Grant | 9,807 | — |
| May 13, 2026 | PAKOLA STEVEofficer: Chief Medical Officer | Sell | 15,309 | $11.02 |
| Mar 12, 2026 | PAKOLA STEVEofficer: Chief Medical Officer | Sell | 5,124 | $10.35 |
| Feb 3, 2026 | Christmas Patrick J.officer: Chief Strategy & Legal Officer | Tax | 4,700 | $11.16 |
| Feb 3, 2026 | PAKOLA STEVEofficer: Chief Medical Officer | Tax | 5,267 | $11.16 |
| Jan 29, 2026 | Mills Kenneth T.director | Option | 225,000 | $13.09 |
| Jan 29, 2026 | Mills Kenneth T.director | Tax | 221,753 | $13.41 |
| Jan 8, 2026 | Christmas Patrick J.officer: Chief Strategy & Legal Officer | Grant | 73,749 | — |
| Jan 8, 2026 | Chan Mitchellofficer: Chief Financial Officer | Grant | 73,749 | — |
| Jan 8, 2026 | Malzahn Craigofficer: Chief Technology Officer | Grant | 65,847 | — |
Source: RGNX SEC Form 4 filings, latest Jul 1, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their RGNX positions over the last 6 months (SEC Form 13F).
Increased
130
New positions
55
Reduced
119
Sold out
42
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Increased | 5.8M | May 13, 2026 |
| BLACKROCK, INC. | Reduced | 5.8M | Feb 12, 2026 |
| REDMILE GROUP, LLC | Unchanged | 4.4M | May 15, 2026 |
| REDMILE GROUP, LLC | Reduced | 4.4M | Feb 17, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 4.0M | May 15, 2026 |
| JPMORGAN CHASE & CO | Reduced | 3.6M | Feb 11, 2026 |
| JPMORGAN CHASE & CO | Reduced | 3.5M | May 13, 2026 |
| VANGUARD GROUP INC | Increased | 3.4M | Jan 29, 2026 |
| STATE STREET CORP | Increased | 2.7M | May 15, 2026 |
| STATE STREET CORP | Increased | 2.3M | Feb 13, 2026 |
| MORGAN STANLEY | Reduced | 2.1M | May 15, 2026 |
| MORGAN STANLEY | Increased | 2.0M | Feb 13, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 1.8M | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 1.8M | Mar 25, 2026 |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | Increased | 1.5M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.